$136.04 -$2.00 (0.0%)

03:39 PM EDT on 05/24/19

Allergan Plc (NYSE:AGN)

CAPS Rating: 5 out of 5

The Company is engaged in the development, manufacture, marketing, sale and distribution of brand and off-patent pharmaceutical products.

Current Price $136.04 Mkt Cap $45.2B
Open $138.49 P/E Ratio 0.00
Prev. Close $136.04 Div. (Yield) $2.97 (2.0%)
Daily Range $135.93 - $139.21 Volume 142,258
52-Wk Range $130.38 - $161.02 Avg. Daily Vol. 55

Caps

How do you think NYSE:AGN will perform against the market?

Add Stock to CAPS Watchlist

All Players

405 Outperform
26 Underperform
 

All-Star Players

97 Outperform
6 Underperform
 

Wall Street

17 Outperform
0 Underperform
 

Top NYSE:AGN Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

bradford86 (99.75)
Submitted January 14, 2012

276. Watson Pharmaceuticals (NYSE: WPI) is down from $70 where it topped in 2011. At the present price of around $62, I think that there is a little upside here. Target: $63-$68. My 2012 EPS estimate is $5.60 which puts this at a P/E of 11.1 for a… More

naughtyguy (34.70)
Submitted March 13, 2014

34 billion market cap! You have got to be kidding!

NYSE:AGN VS S&P 500 (SPY)

Fools bullish on NYSE:AGN are also bullish on:

Fools bearish on NYSE:AGN are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about AGN.

Recs

0
Member Avatar ERojo (< 20) Submitted: 3/1/2019 5:55:30 AM : Outperform Start Price: $137.71 NYSE:AGN Score: -2.13

botox brand is very valuable
secular growth in aesthetics
luxury product

Recs

0
Member Avatar jsn1080 (26.13) Submitted: 5/22/2018 2:01:17 PM : Outperform Start Price: $152.77 NYSE:AGN Score: -14.36

This is a value play

Forward P/E: 9.29

Price to book: 0.74

Debt to Capital: 26.0%

Interest Coverage: 5 (est based on Forward P/E)

Forward Dividend : 1.73%

Payout Ratio: 18%

Credit Rating: BBB

Recs

0
Member Avatar XMFRendezvous (92.65) Submitted: 4/21/2018 6:48:15 PM : Outperform Start Price: $155.90 NYSE:AGN Score: -18.63

Mr. Market has been tough on a few biotechs recently. Botox has been Allergan's cash cow. They have excellent long term focused management (as seen in Valeant documentary) and are starting to develop Biosimilar drugs through acquisition which is the future of reducing costs of health care and should expand their market. It is the anti-Valeant model.

This and Celgene might be my favorite bigger biotech companies.

Leaderboard

Find the members with the highest scoring picks in AGN.

Score Leader

darkstrike2

darkstrike2 (< 20) Score: +893.25

The Score Leader is the player with the highest score across all their picks in AGN.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
rustat82 78.13 11/22/2006 Outperform 1Y $23.99 +467.00% +113.27% +353.73 0 Comment
Sempre57 45.42 11/22/2006 Outperform 3W $24.23 +461.44% +113.21% +348.23 0 Comment
blazin1 < 20 11/21/2006 Outperform 3M $24.26 +460.68% +113.66% +347.02 0 Comment
snoopaloop 59.08 11/20/2006 Outperform 5Y $24.29 +460.02% +114.20% +345.82 0 Comment
trustee74 83.05 12/8/2006 Outperform 3Y $24.56 +453.85% +113.25% +340.60 0 Comment
NetscribePhrmtcl 80.57 1/17/2007 Outperform 1Y $24.90 +446.34% +110.28% +336.06 2 Comments
IBSpud < 20 1/12/2007 4/19/2012 Outperform 3Y $25.06 +442.77% +110.65% +332.12 0 Comment
JockDasher 50.26 1/12/2007 Outperform 1Y $25.11 +441.72% +111.37% +330.35 0 Comment
tdchayes 87.89 10/10/2006 Outperform 3M $24.83 +447.83% +122.01% +325.82 0 Comment
harposun < 20 1/10/2007 Outperform 1Y $25.29 +438.00% +113.13% +324.87 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
trackmizuho < 20 8/19/2016 Outperform NS $244.39 -44.33% +29.64% -73.98 0 Comment
TrackDeutscheSec 82.30 7/23/2014 Outperform NS $210.24 -35.29% +42.58% -77.88 0 Comment
TrackCanaccord 66.57 6/27/2014 Outperform NS $216.70 -37.22% +45.15% -82.38 0 Comment
TrackJimCramer 85.98 6/17/2013 Outperform 3W $120.58 +12.82% +72.11% -59.29 0 Comment
TrackCRTCapital 46.12 5/13/2013 Outperform NS $114.72 +18.58% +73.42% -54.84 0 Comment
TrackPiperJaff 85.88 11/2/2012 Outperform NS $85.31 +59.47% +96.98% -37.51 0 Comment
TrackCreditSuiss 89.36 11/1/2012 Outperform NS $86.86 +56.62% +99.80% -43.18 0 Comment
TrackZacks < 20 10/19/2012 Outperform 3M $86.91 -1.70% -3.41% +1.70 11/12/2012 @ $85.43 1 Comment
TrackZacks < 20 8/27/2012 Outperform 3M $82.65 +5.48% +1.88% +3.60 10/9/2012 @ $87.18 1 Comment
TrackBernstein 88.73 6/22/2012 Outperform NS $68.34 +99.06% +112.59% -13.53 0 Comment
TrackZacks < 20 5/17/2012 Outperform 3M $70.87 +10.64% +8.33% +2.31 8/21/2012 @ $78.41 1 Comment
TrackCitigroup 88.48 4/26/2012 Outperform NS $73.11 +86.08% +103.77% -17.69 0 Comment
TrackJPMorgan 84.63 4/26/2012 Outperform NS $73.11 +86.08% +103.77% -17.69 0 Comment
TrackZacks < 20 4/5/2012 Outperform 3M $67.56 +10.14% +0.26% +9.87 4/26/2012 @ $74.41 1 Comment
TrackBarclaysCap 88.04 12/9/2011 Outperform NS $61.94 +274.36% +57.80% +216.56 9/23/2014 @ $231.88 0 Comment
TrackGoldmanSach 78.84 10/20/2011 Outperform 5Y $66.63 +234.44% +68.64% +165.80 5/13/2016 @ $222.84 1 Comment
TrackCollinsStew 70.34 7/26/2011 Outperform NS $66.18 +105.56% +111.92% -6.36 0 Comment
TrackZacks < 20 7/25/2011 Outperform 3M $69.36 -13.25% +4.66% -17.91 3/13/2012 @ $60.17 1 Comment
TrackZacks < 20 6/21/2011 Outperform 3M $65.70 -0.38% -1.17% +0.79 6/27/2011 @ $65.45 1 Comment
TrackZacks < 20 5/27/2011 Outperform 3M $63.99 +0.75% -3.81% +4.56 6/8/2011 @ $64.47 1 Comment
TrackArgus 83.21 10/4/2010 Outperform NS $42.21 +222.26% +147.46% +74.80 0 Comment
TrackNeedham 90.04 3/4/2010 Underperform NS $39.94 +7.01% +7.19% +0.18 4/16/2010 @ $42.74 0 Comment
TrackPiperJaff 85.88 3/4/2010 Underperform NS $39.94 +121.31% +27.50% -93.81 11/2/2012 @ $88.39 0 Comment
TrackSunTrustRH 79.47 12/10/2009 Outperform NS $37.99 +106.98% +25.00% +81.97 7/30/2012 @ $78.63 0 Comment
TrackRBCCapMkts 85.49 4/23/2009 Outperform NS $28.27 +381.24% +237.58% +143.66 0 Comment
TrackStanfordRes < 20 1/22/2009 Outperform NS $24.33 +174.97% +67.35% +107.62 4/17/2012 @ $66.90 0 Comment
TrackCreditSuiss 89.36 11/6/2008 Underperform NS $24.40 +250.33% +49.78% -200.54 10/31/2012 @ $85.48 0 Comment
TrackWellsFargo 87.31 9/22/2008 Outperform NS $27.97 +386.39% +133.06% +253.33 0 Comment
TrackJimCramer 85.98 9/4/2008 Underperform 3W $30.26 +312.89% +32.58% -280.31 6/17/2013 @ $124.94 0 Comment
TrackJimCramer 85.98 7/21/2008 Outperform 3W $29.30 +3.28% -1.60% +4.88 9/4/2008 @ $30.26 0 Comment
TrackSoros 82.87 3/31/2008 Outperform NS $28.30 +380.75% +122.40% +258.36 1 Comment
TrackWRHambrecht < 20 2/19/2008 Outperform NS $28.52 +134.57% +0.91% +133.66 4/17/2012 @ $66.90 0 Comment
TrackEdwardOwens 98.92 9/30/2007 Outperform NS $31.27 +335.05% +94.34% +240.71 2 Comments
TrackRothCapital 71.42 9/28/2007 Outperform NS $33.00 +89.06% -11.42% +100.48 5/3/2011 @ $62.39 0 Comment
TrackUBS 91.28 5/2/2007 Outperform NS $28.96 +369.69% +100.94% +268.75 0 Comment
TrackRothCapital 71.42 11/8/2006 Outperform NS $25.45 +5.11% +2.14% +2.97 2/28/2007 @ $26.75 0 Comment
TrackJimCramer 85.98 10/27/2006 Underperform 3W $26.67 +9.86% -8.30% -18.16 7/22/2008 @ $29.30 0 Comment
TrackFTNEquityCa < 20 10/17/2006 Outperform NS $26.56 +151.88% +1.17% +150.71 4/17/2012 @ $66.90 0 Comment

Advertisement